Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Cattles

Immunological veterinary medicinal products, including vaccines, are authorised for cattle.

Search results 1 to 25 from a total of 63

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Aniserin orinject

Serum gegen Rotavirus-Infektion,
Coronavirus-Infektion,
E. coli-Infektion

aniMedica GmbH

107a/91 22.09.1994 Rind

Locatim

Serum gegen E. coli-Infektion

Biokema Europe, Liechtenstein

EU/2/99/011/001 28.04.1999 Rind

EPAR: Locatim

BOVALTO Respi 4

Enzootische Bronchopneumonie,
BRSV-Infektion, Parainfluenza-3, BVD/MD, Pasteurellose

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11802.01.1 01.12.2015 Rind

Insol Trichophyton

Trichophytie

Boehringer Ingelheim Vetmedica GmbH

277a/94 26.10.1995 Rind

BOVALTO Respi 3

Enzootische Bronchopneumonie,
BRSV-Infektion, Parainfluenza-3, Pasteurellose

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11801.01.1 01.12.2015 Rind

Aftopur DOE

Maul- und Klauenseuche

Boehringer Ingelheim Vetmedica GmbH

BFAV-B 367 17.12.2003 Rind, Schaf, Ziege, Schwein

Rabisin

Tollwut

Boehringer Ingelheim Vetmedica GmbH

94a/84 24.11.2005 Hund, Katze, Frettchen, Pferd, Rind, Schaf, Nerz

Bovela

BVD/MD

Boehringer Ingelheim Vetmedica GmbH

EU/2/14/176/001-016 22.12.2014 Rind

EPAR: Bovela

Fencovis

Rotavirus-Infektion, Corona-Infektion, E. coli-Infektion

Boehringer Ingelheim Vetmedica GmbH

PEI.V.12116.01.1 25.07.2022 Rind

BTVPUR

Blauzungenkrankheit, Serotypen 1, 2, 4 oder 8

Boehringer Ingelheim Vetmedica GmbH

EU/2/10/113/001-050 17.12.2010 Rind, Schaf

EPAR: BTVPUR

Aftovaxpur DOE

Maul- und Klauenseuche

Boehringer Ingelheim Vetmedica GmbH

EU/2/13/153/001-850 15.07.2013 Rind, Schaf, Schwein

EPAR: Aftovaxpur DOE

Aftopur AlSap

Maul- und Klauenseuche

Boehringer Ingelheim Vetmedica GmbH

BFAV-B 366 17.12.2003 Rind, Schaf, Ziege

BOVALTO Respi Intranasal

BRSV-Infektion, Parainfluenza-3

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11947.01.1 19.03.2018 Rind

Coxevac

Q-Fieber

CEVA Sante Animale, Frankreich

EU/2/10/110/001-002 30.09.2010 Rind, Ziege

EPAR: Coxevac

Trichovac LTF 130

Trichophytie

Ceva Tiergesundheit GmbH

95a/97 30.03.1999 Rind

Mucosiffa

BVD/MD

Ceva Tiergesundheit GmbH

PEI.V.03518.01.1 06.03.2008 Rind

Tricholor

Trichophytie

Ceva Tiergesundheit GmbH

PEI.V.12134.01.1 07.12.2021 Rind

Bluevac BTV

Blauzungenkrankheit, Serotyp 8, 4 oder 1

CZ Veterinaria S.A., Spanien

EU/2/11/122/001-003 14.04.2011 Schaf, Rind

EPAR: Bluevac BTV

CZV BOVINES TUBERCULIN PPD

Tuberkulin zur Feststellung von Mycobacterium bovis- Infektionen

CZ Veterinaria S.A., Spanien

PEI.V.11529.01.1 28.09.2011 Rind

Bluevac-4

Blauzungenkrankheit, Serotyp 4

CZ Veterinaria S.A., Spanien

PEI.V.11839.01.1 25.05.2016 Schaf, Rind

Biofakt Albrecht

Serum gegen Rotavirus-Infektion,
Coronavirus-Infektion,
E. coli-Infektion

Dechra Veterinary Products Deutschland GmbH

PEI.V.03587.01.1 14.06.2008 Rind

Bovitrichon

Trichophytie

Ecuphar NV, Belgien

PEI.V.01863.02.1 10.12.2014 Rind

BOVIGEN SCOUR

Rotavirus-Infektion, Coronavirus-Infektion,
E. coli-Infektion

FORTE Healthcare Ltd., Irland

PEI.V.11715.01.1 24.02.2015 Rind

Bravoxin 10

Enterotoxämie, Rauschbrand, Pararauschbrand, Deutsche Bradsot, Gasödem, Tetanus, Infektiöse Hämoglobinurie

Intervet Deutschland GmbH

PEI.V.03633.01.1 21.10.2008 Rind, Schaf

Bovilis Rotavec Corona

Rotavirus-Infektion, Coronavirus-Infektion, E.coli-Infektion

Intervet Deutschland GmbH

PEI.V.01312.01.1 13.04.2000 Rind

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 518 in BAnz AT 26.06.2024 B7.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 26.06.2024